Liposomal bupivacaine
101719
Approved small_molecule active
Quick answer
Liposomal bupivacaine for Liposomal Bupivacaine is a Approved program (small_molecule) at Black Diamond Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Black Diamond Therapeutics
- Indication
- Liposomal Bupivacaine
- Phase
- Approved
- Modality
- small_molecule
- Status
- active